What is the Impact Factor of Therapeutic Advances in Musculoskeletal Disease?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Musculoskeletal Disease is 3.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Therapeutic Advances in Musculoskeletal Disease indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Musculoskeletal Disease is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.190 (Q1) and an H-index of 59.

Who publishes Therapeutic Advances in Musculoskeletal Disease and what is the Article Processing Charge (APC)?

Therapeutic Advances in Musculoskeletal Disease is published by SAGE Publications Inc.. The estimated Article Processing Charge (APC) is approximately $3,390 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Musculoskeletal Disease?

The official ISO-4 abbreviation of Therapeutic Advances in Musculoskeletal Disease is "THER ADV MUSCULOSKEL" with common acronym "tamd". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #3,691Hybrid

Therapeutic Advances in Musculoskeletal Disease

Acronym:tamd

•

Abbreviation (ISO):THER ADV MUSCULOSKEL

•

Identifier (ISSN):1759-720X(Print)/1759-7218(Online)

•

Publisher:SAGE Publications Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.3↓ -0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Advances in Musculoskeletal Disease

WoS Q2

Annual Impact Factor Metric

Current (2026):3.3

Scopus SJR & RankScopus Q1

1.19

#3,691

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

59 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate2.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

102articles/year

99.34% Gold OA•61.9% Original Research

Aims & Scope

Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of musculoskeletal disease.

Topics Covered (Recognized by AI)

MedicineInternal MedicineBiologyPathologyImmunologySurgeryPathology & DiseasesGeneticsPsychologyEndocrinologyPsychiatryChemistryMathematicsBiochemistryStatisticsAlternative MedicinePhysical TherapyRadiologyPharmacologyBioinformatics

Primary Research Areas

Medicine Rheumatology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RHEUMATOLOGY

Rank20/58

IndexSCIE

JCISCIE2026

RHEUMATOLOGY

Rank23/58

IndexSCIE

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRSCIE	20/58	Q2
RHEUMATOLOGY	JCISCIE	23/58	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.3

Articles / Year96

Total Citations41

2025

IF4.1

Articles / Year49

Total Citations172

2024

IF3.4

Articles / Year55

Total Citations499

2023

IF4.2

Articles / Year51

Total Citations646

2022

IF3.625

Articles / Year107

Total Citations2,063

Year	Impact Factor	Articles / Year	Total Citations
2026	3.3	96	41
2025	4.1	49	172
2024	3.4	55	499
2023	4.2	51	646
2022	3.625	107	2,063
2021	5.346	111	2,422
2020	5.043	85	2,401
2019	5.045	38	1,220
2018	3.45	21	1,231
2017	—	26	1,688
2016	—	24	1,262
2015	—	22	849

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,691Scopus Q1SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.19

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.47

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,390 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations867

3-Year Documents212

Citable Documents211

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Orthopedics and Sports MedicineQ1

RheumatologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Musculoskeletal Disease (acronym: tamd, abbr: THER ADV MUSCULOSKEL, ISSN: 1759-720X) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.190 (Q1), an H-index of 59.

The journal enforces rigorous peer evaluation with an annual output of approximately 102 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,390 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.